{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:55:34Z","timestamp":1793325334315,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Osteoporosis, the most common metabolic bone disease and a global health problem, is the result of abnormal bone architecture and bone loss, leading to bone fragility and an increased risk of fractures. A fragility or low-trauma fracture is the first clinical sign of osteoporosis and is typically associated with a significant risk of future fractures. Practical screening tools and guidelines are critical for fracture prevention. Dual X-ray absorptiometry (DXA) is the gold standard for risk stratification and diagnosis of osteoporosis. In this review, we report recent advances in in DXA screening and bone density evaluation for patients at risk of fragility fracture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>DXA measures bone density as an absolute measure (g\/cm2) and also reports the patient\u2019s bone mineral density (BMD) as a comparison to a standard population, which is the basis of the World Health Organization (WHO) classification for osteoporosis. DXA also provides vertebral fracture assessment (VFA), an additional tool to assess vertebral fracture presence and increased fracture risk. Understanding the methodology, reporting, and limitations of DXA use is critical for appropriate utilization of the test. BMD is validated as a predictor of fracture risk and may be used with or without clinical risk factors as part of the FRAX fracture risk assessment tool to accurately assess an individual\u2019s fracture risk. In this review, we discuss the role of DXA in screening, diagnosis, and treatment of osteoporosis. We include FRAX and its limitations, trabecular bone score (TBS), quantitative computed tomography (qCT) the American College of Rheumatology (ACR) updates on the management of glucocorticoid-induced osteoporosis, the updated International Society of Clinical Densitometry (ISCD) Position Statements, and report the key features of DXA testing, reporting, and utilization in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>DXA plays a critical role in BMD evaluation and fracture risk assessment. Appropriate utilization of this tool in clinical practice, through accurate interpretation and application of results, is essential for effective fracture prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11926-025-01205-9","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:13:53Z","timestamp":1761959633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Updates on the Role of DXA in the Evaluation and Monitoring of Osteoporosis"],"prefix":"10.1007","volume":"27","author":[{"given":"Shahane","family":"Anupama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian Yik","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcy B.","family":"Bolster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,1]]},"reference":[{"key":"1205_CR1","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2018.6537","volume":"319","author":"M Viswanathan","year":"2018","unstructured":"Viswanathan M, Reddy S, Berkman N, Cullen K, Middleton JC, Nicholson WK, et al. Screening to prevent osteoporotic fractures: updated evidence report and systematic review for the US preventive services task force. JAMA. 2018;319:2532\u201351.","journal-title":"JAMA"},{"key":"1205_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1359\/jbmr.061113","volume":"22","author":"R Burge","year":"2007","unstructured":"Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the united States, 2005\u20132025. J Bone Miner Res. 2007;22:465\u201375.","journal-title":"J Bone Miner Res"},{"key":"1205_CR3","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R. National osteoporosis F: clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25:2359\u201381.","journal-title":"Osteoporos Int"},{"key":"1205_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10192","volume":"3","author":"EM Lewiecki","year":"2019","unstructured":"Lewiecki EM, Ortendahl JD, Vanderpuye-Orgle J, Grauer A, Arellano J, Lemay J, et al. Healthcare policy changes in osteoporosis can improve outcomes and reduce costs in the United States. JBMR Plus. 2019;3:e10192.","journal-title":"JBMR Plus"},{"key":"1205_CR5","unstructured":"In Bone Health and Osteoporosis: A Report of the Surgeon General. Edited by. 2004. Reports of the Surgeon General."},{"key":"1205_CR6","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2106\/JBJS.G.01121","volume":"90","author":"TD Rozental","year":"2008","unstructured":"Rozental TD, Makhni EC, Day CS, Bouxsein ML. Improving evaluation and treatment for osteoporosis following distal radial fractures. A prospective randomized intervention. J Bone Joint Surg Am. 2008;90:953\u201361.","journal-title":"J Bone Joint Surg Am"},{"key":"1205_CR7","first-page":"105","volume":"133","author":"MA Clynes","year":"2020","unstructured":"Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM, Cooper C. The epidemiology of osteoporosis. Br Med Bull. 2020;133:105\u201317.","journal-title":"Br Med Bull"},{"key":"1205_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/jbmr.5650110602","volume":"11","author":"HK Genant","year":"1996","unstructured":"Genant HK, Engelke K, Fuerst T, Gluer CC, Grampp S, Harris ST, et al. Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res. 1996;11:707\u201330.","journal-title":"J Bone Miner Res"},{"key":"1205_CR9","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","volume":"359","author":"JA Kanis","year":"2002","unstructured":"Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359:1929\u201336.","journal-title":"Lancet"},{"key":"1205_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2023.101437","volume":"27","author":"D Krueger","year":"2024","unstructured":"Krueger D, Tanner SB, Szalat A, Malabanan A, Prout T, Lau A, et al. DXA reporting updates: 2023 official positions of the international society for clinical densitometry. J Clin Densitom. 2024;27:101437.","journal-title":"J Clin Densitom"},{"key":"1205_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jocd.2019.07.001","volume":"22","author":"CR Shuhart","year":"2019","unstructured":"Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR, et al. Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. J Clin Densitom. 2019;22:453\u201371.","journal-title":"J Clin Densitom"},{"key":"1205_CR12","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"JA Kanis","year":"1994","unstructured":"Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137\u201341.","journal-title":"J Bone Miner Res"},{"key":"1205_CR13","doi-asserted-by":"crossref","unstructured":"LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, Siris ES. The clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 2022.","DOI":"10.1007\/s00198-021-05900-y"},{"key":"1205_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41574-020-0339-7","volume":"16","author":"IR Reid","year":"2020","unstructured":"Reid IR. A broader strategy for osteoporosis interventions. Nat Rev Endocrinol. 2020;16:333\u20139.","journal-title":"Nat Rev Endocrinol"},{"key":"1205_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bone.2018.06.004","volume":"114","author":"K Trajanoska","year":"2018","unstructured":"Trajanoska K, Schoufour JD, de Jonge EAL, Kieboom BCT, Mulder M, Stricker BH, et al. Fracture incidence and secular trends between 1989 and 2013 in a population based cohort: the Rotterdam study. Bone. 2018;114:116\u201324.","journal-title":"Bone"},{"key":"1205_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00223-018-0476-3","volume":"104","author":"RMH Tei","year":"2019","unstructured":"Tei RMH, Ramlau-Hansen CH, Plana-Ripoll O, Brink O, Langdahl BL. OFELIA: prevalence of osteoporosis in fragility fracture patients. Calcif Tissue Int. 2019;104:102\u201314.","journal-title":"Calcif Tissue Int"},{"key":"1205_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1089\/jwh.2010.2294","volume":"20","author":"NB Watts","year":"2011","unstructured":"Watts NB. The fracture risk assessment tool (FRAX(R)): applications in clinical practice. J Womens Health (Larchmt). 2011;20:525\u201331.","journal-title":"J Womens Health (Larchmt)"},{"key":"1205_CR18","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.bone.2009.01.373","volume":"44","author":"JA Kanis","year":"2009","unstructured":"Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E. FRAX and its applications to clinical practice. Bone. 2009;44:734\u201343.","journal-title":"Bone"},{"key":"1205_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s40618-023-02219-9","volume":"47","author":"M Schini","year":"2024","unstructured":"Schini M, Johansson H, Harvey NC, Lorentzon M, Kanis JA, McCloskey EV. An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis. J Endocrinol Invest. 2024;47:501\u201311.","journal-title":"J Endocrinol Invest"},{"key":"1205_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-016-0278-z","volume":"11","author":"JA Kanis","year":"2016","unstructured":"Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV, et al. A systematic review of intervention thresholds based on FRAX: a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos. 2016;11:25.","journal-title":"Arch Osteoporos"},{"key":"1205_CR21","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2018.7498","volume":"319","author":"USPST Force","year":"2018","unstructured":"Force USPST, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr., Kemper AR, et al. Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement. JAMA. 2018;319:2521\u201331.","journal-title":"JAMA"},{"issue":"Suppl 2","key":"1205_CR22","doi-asserted-by":"publisher","first-page":"S407","DOI":"10.1007\/s00198-010-1253-y","volume":"21","author":"JA Kanis","year":"2010","unstructured":"Kanis JA, McCloskey EV, Johansson H, Oden A, Strom O, Borgstrom F. Development and use of FRAX in osteoporosis. Osteoporos Int. 2010;21(Suppl 2):S407\u2013413.","journal-title":"Osteoporos Int"},{"key":"1205_CR23","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1210\/jc.2004-1568","volume":"90","author":"SA Wainwright","year":"2005","unstructured":"Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, Hochberg MC, Vogt MT, Orwoll ES. Study of osteoporotic fractures research G: hip fracture in women without osteoporosis. J Clin Endocrinol Metab. 2005;90:2787\u201393.","journal-title":"J Clin Endocrinol Metab"},{"key":"1205_CR24","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/archinte.164.10.1108","volume":"164","author":"ES Siris","year":"2004","unstructured":"Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164:1108\u201312.","journal-title":"Arch Intern Med"},{"key":"1205_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00198-022-06633-2","volume":"34","author":"JA Kanis","year":"2023","unstructured":"Kanis JA, Johansson H, Harvey NC, Lorentzon M, Liu E, Vandenput L, et al. Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year. Osteoporos Int. 2023;34:479\u201387.","journal-title":"Osteoporos Int"},{"key":"1205_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-019-05176-3","volume":"31","author":"JA Kanis","year":"2020","unstructured":"Kanis JA, Harvey NC, McCloskey E, Bruyere O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, et al. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int. 2020;31:1\u201312.","journal-title":"Osteoporos Int"},{"key":"1205_CR27","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00198-018-4502-0","volume":"29","author":"JA Kanis","year":"2018","unstructured":"Kanis JA, Johansson H, Oden A, Harvey NC, Gudnason V, Sanders KM, et al. Characteristics of recurrent fractures. Osteoporos Int. 2018;29:1747\u201357.","journal-title":"Osteoporos Int"},{"issue":"5","key":"1205_CR28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00223-014-9911-2","volume":"95","author":"H Johansson","year":"2014","unstructured":"Johansson H, Kanis JA, Oden A, Leslie WD, Fujiwara S, Gluer CC, et al. Impact of femoral neck and lumbar spine BMD discordances on FRAX probabilities in women: a meta-analysis of international cohorts. Calcif Tissue Int. 2014;95(5):428\u201335.","journal-title":"Calcif Tissue Int"},{"key":"1205_CR29","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/jbmr.3538","volume":"33","author":"WD Leslie","year":"2018","unstructured":"Leslie WD, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Hans D. Comparison of methods for improving fracture risk assessment in diabetes: the Manitoba BMD registry. J Bone Miner Res. 2018;33:1923\u201330.","journal-title":"J Bone Miner Res"},{"key":"1205_CR30","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/jbmr.2734","volume":"31","author":"EV McCloskey","year":"2016","unstructured":"McCloskey EV, Oden A, Harvey NC, Leslie WD, Hans D, Johansson H, et al. A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res. 2016;31:940\u20138.","journal-title":"J Bone Miner Res"},{"key":"1205_CR31","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1002\/acr.25240","volume":"75","author":"MB Humphrey","year":"2023","unstructured":"Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, Caplan L, Gore S, Grossman J, Hansen KE, et al. 2022 American college of rheumatology guideline for the prevention and treatment of Glucocorticoid-Induced osteoporosis. Arthritis Care Res (Hoboken). 2023;75:2405\u201319.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1205_CR32","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","volume":"18","author":"E Canalis","year":"2007","unstructured":"Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007;18:1319\u201328.","journal-title":"Osteoporos Int"},{"key":"1205_CR33","doi-asserted-by":"publisher","first-page":"919","DOI":"10.7326\/0003-4819-114-11-919","volume":"114","author":"PD Ross","year":"1991","unstructured":"Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991;114:919\u201323.","journal-title":"Ann Intern Med"},{"key":"1205_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bone.2012.09.023","volume":"52","author":"A El Maghraoui","year":"2013","unstructured":"El Maghraoui A, Rezqi A, Mounach A, Achemlal L, Bezza A, Ghozlani I. Systematic vertebral fracture assessment in asymptomatic postmenopausal women. Bone. 2013;52:176\u201380.","journal-title":"Bone"},{"key":"1205_CR35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jocd.2017.06.016","volume":"20","author":"JLC Borges","year":"2017","unstructured":"Borges JLC, de Lewiecki MMIS. The clinical utility of vertebral fracture assessment in predicting fractures. J Clin Densitom. 2017;20:304\u20138.","journal-title":"J Clin Densitom"},{"key":"1205_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-021-01046-w","volume":"17","author":"JM Mostert","year":"2021","unstructured":"Mostert JM, Romeijn SR, Dibbets-Schneider P, Rietbergen DDD, Pereira Arias-Bouda LM, Gotz C, et al. Inter-observer agreement of vertebral fracture assessment with dual-energy x-ray absorptiometry equipment. Arch Osteoporos. 2021;17:4.","journal-title":"Arch Osteoporos"},{"key":"1205_CR37","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/acr.23279","volume":"69","author":"L Buckley","year":"2017","unstructured":"Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, Humphrey MB, Lane NE, Magrey M, Miller M, et al. 2017 American college of rheumatology guideline for the prevention and treatment of Glucocorticoid-Induced osteoporosis. Arthritis Care Res (Hoboken). 2017;69:1095\u2013110.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1205_CR38","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1007\/s00198-020-05588-6","volume":"31","author":"J Yang","year":"2020","unstructured":"Yang J, Cosman F, Stone PW, Li M, Nieves JW. Vertebral fracture assessment (VFA) for osteoporosis screening in US postmenopausal women: is it cost-effective? Osteoporos Int. 2020;31:2321\u201335.","journal-title":"Osteoporos Int"},{"key":"1205_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/jbmr.558","volume":"27","author":"TA Hillier","year":"2012","unstructured":"Hillier TA, Lui LY, Kado DM, LeBlanc ES, Vesco KK, Bauer DC, et al. Height loss in older women: risk of hip fracture and mortality independent of vertebral fractures. J Bone Miner Res. 2012;27:153\u20139.","journal-title":"J Bone Miner Res"},{"key":"1205_CR40","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jocd.2019.07.005","volume":"22","author":"JLC Borges","year":"2019","unstructured":"Borges JLC, Sousa da Silva M, Ward RJ, Diemer KM, Yeap SS, Lewiecki EM. Repeating vertebral fracture assessment: 2019 ISCD official position. J Clin Densitom. 2019;22:484\u20138.","journal-title":"J Clin Densitom"},{"key":"1205_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","volume":"19","author":"AN Tosteson","year":"2008","unstructured":"Tosteson AN, Melton LJ 3rd, Dawson-Hughes B, Baim S, Favus MJ, Khosla S, Lindsay RL. National osteoporosis foundation guide C: Cost-effective osteoporosis treatment thresholds: the united States perspective. Osteoporos Int. 2008;19:437\u201347.","journal-title":"Osteoporos Int"},{"key":"1205_CR42","doi-asserted-by":"publisher","first-page":"564","DOI":"10.4158\/GL-2020-0524","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, et al. American association of clinical endocrinologists\/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis- 2020 update executive summary. Endocr Pract. 2020;26:564\u201370.","journal-title":"Endocr Pract"},{"key":"1205_CR43","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/jama.2024.27154","volume":"333","author":"USPST Force","year":"2025","unstructured":"Force USPST, Nicholson WK, Silverstein M, Wong JB, Chelmow D, Coker TR, Davis EM, Jaen CR, Krousel-Wood M, Lee S, et al. Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement. JAMA. 2025;333:498\u2013508.","journal-title":"JAMA"},{"key":"1205_CR44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11914-010-0022-3","volume":"8","author":"JP van den Bergh","year":"2010","unstructured":"van den Bergh JP, van Geel TA, Lems WF, Geusens PP. Assessment of individual fracture risk: FRAX and beyond. Curr Osteoporos Rep. 2010;8:131\u20137.","journal-title":"Curr Osteoporos Rep"},{"key":"1205_CR45","doi-asserted-by":"crossref","unstructured":"Li T, Ihanus A, Ohukainen P, Jarvelin MR, Kahonen M, Kettunen J, Raitakari OT, Lehtimaki T, Makinen VP, Tynkkynen T et al. Clinical and biochemical associations of urinary metabolites: quantitative epidemiological approach on renal-cardiometabolic biomarkers. Int J Epidemiol 2024, 53.","DOI":"10.1093\/ije\/dyad162"},{"key":"1205_CR46","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1385\/JCD:3:2:133","volume":"3","author":"RB Mazess","year":"2000","unstructured":"Mazess RB, Nord R, Hanson JA, Barden HS. Bilateral measurement of femoral bone mineral density. J Clin Densitom. 2000;3:133\u201340.","journal-title":"J Clin Densitom"},{"key":"1205_CR47","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1385\/JCD:6:4:353","volume":"6","author":"KG Faulkner","year":"2003","unstructured":"Faulkner KG. Improving femoral bone density measurements. J Clin Densitom. 2003;6:353\u20138.","journal-title":"J Clin Densitom"},{"key":"1205_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/jbmr.4444","volume":"37","author":"A Moilanen","year":"2022","unstructured":"Moilanen A, Kopra J, Kroger H, Sund R, Rikkonen T, Sirola J. Characteristics of long-term femoral neck bone loss in postmenopausal women: a 25-year follow-up. J Bone Miner Res. 2022;37:173\u20138.","journal-title":"J Bone Miner Res"},{"key":"1205_CR49","doi-asserted-by":"publisher","first-page":"e3877","DOI":"10.1210\/clinem\/dgac324","volume":"107","author":"KE Ensrud","year":"2022","unstructured":"Ensrud KE, Lui LY, Crandall CJ, Orwoll ES, Langsetmo L, Schousboe JT, Fink HA, Lane NE, Kado DM, Cauley JA, et al. Repeat bone mineral density screening measurement and fracture prediction in older men: A prospective cohort study. J Clin Endocrinol Metab. 2022;107:e3877\u201386.","journal-title":"J Clin Endocrinol Metab"},{"key":"1205_CR50","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1359\/JBMR.050814","volume":"20","author":"NB Watts","year":"2005","unstructured":"Watts NB, Geusens P, Barton IP, Felsenberg D. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD. J Bone Miner Res. 2005;20:2097\u2013104.","journal-title":"J Bone Miner Res"},{"key":"1205_CR51","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/jbmr.4333","volume":"36","author":"GA Kline","year":"2021","unstructured":"Kline GA, Lix LM, Leslie WD. Patient outcomes in the years after a DXA-BMD treatment monitoring test: improved medication adherence in some, but too little too late. J Bone Miner Res. 2021;36:1425\u201331.","journal-title":"J Bone Miner Res"},{"key":"1205_CR52","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1210\/jc.2014-3777","volume":"100","author":"WD Leslie","year":"2015","unstructured":"Leslie WD, Majumdar SR, Morin SN, Lix LM. Why does rate of bone density loss not predict fracture risk? J Clin Endocrinol Metab. 2015;100:679\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"1205_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2023.101440","volume":"27","author":"LU Gani","year":"2024","unstructured":"Gani LU, Sritara C, Blank RD, Chen W, Gilmour J, Dhaliwal R, et al. Follow-up bone mineral density testing: 2023 official positions of the international society for clinical densitometry. J Clin Densitom. 2024;27:101440.","journal-title":"J Clin Densitom"},{"key":"1205_CR54","unstructured":"MEDIMAPS. Trabecular Bone Score (TBS). Edited by: MEDIMAPS 2025."},{"key":"1205_CR55","unstructured":"MEDIMAPS. Trabecular bone score: a paradigm shift in osteoporosis assessment and management. Edited by MEDIMAPS."},{"key":"1205_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2023.101452","volume":"27","author":"H Goel","year":"2024","unstructured":"Goel H, Binkley N, Boggild M, Chan WP, Leslie WD, McCloskey E, et al. Clinical use of trabecular bone score: the 2023 ISCD official positions. J Clin Densitom. 2024;27:101452.","journal-title":"J Clin Densitom"},{"key":"1205_CR57","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00198-023-06817-4","volume":"34","author":"E Shevroja","year":"2023","unstructured":"Shevroja E, Reginster JY, Lamy O, Al-Daghri N, Chandran M, Demoux-Baiada AL, et al. Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO), and the international osteoporosis foundation (IOF) under the auspices of WHO collaborating center for epidemiology of musculoskeletal health and aging. Osteoporos Int. 2023;34:1501\u201329.","journal-title":"Osteoporos Int"},{"key":"1205_CR58","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00259-024-06912-6","volume":"52","author":"R Slart","year":"2025","unstructured":"Slart R, Punda M, Ali DS, Bazzocchi A, Bock O, Camacho P, et al. Updated practice guideline for dual-energy X-ray absorptiometry (DXA). Eur J Nucl Med Mol Imaging. 2025;52:539\u201363.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1205_CR59","volume":"20","author":"R Zerikly","year":"2024","unstructured":"Zerikly R, Demetriou EW. Use of fracture risk assessment tool in clinical practice and fracture risk assessment tool future directions. Womens Health. 2024;20:17455057241231387.","journal-title":"Womens Health"},{"key":"1205_CR60","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0001-2998(87)80024-7","volume":"17","author":"HK Genant","year":"1987","unstructured":"Genant HK, Block JE, Steiger P, Glueer CC, Smith R. Quantitative computed tomography in assessment of osteoporosis. Semin Nucl Med. 1987;17:316\u201333.","journal-title":"Semin Nucl Med"},{"key":"1205_CR61","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ejrad.2009.04.074","volume":"71","author":"JE Adams","year":"2009","unstructured":"Adams JE. Quantitative computed tomography. Eur J Radiol. 2009;71:415\u201324.","journal-title":"Eur J Radiol"},{"key":"1205_CR62","unstructured":"MINDWAY CT. QCT vs. DXA: What\u2019s the Score. Edited by MINDWAY CT."},{"key":"1205_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/s40134-014-0065-9","volume":"2","author":"X Li","year":"2014","unstructured":"Li X, Na L, Xiaoguang C. Update on the clinical application of quantitative computed tomography (QCT) in osteoporosis. Curr Radiol Rep. 2014;2:65.","journal-title":"Curr Radiol Rep"},{"key":"1205_CR64","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jocd.2015.06.013","volume":"18","author":"JA Shepherd","year":"2015","unstructured":"Shepherd JA, Schousboe JT, Broy SB, Engelke K, Leslie WD. Executive summary of the 2015 ISCD position development conference on advanced measures from DXA and QCT: fracture prediction beyond BMD. J Clin Densitom. 2015;18:274\u201386.","journal-title":"J Clin Densitom"},{"key":"1205_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2023.101439","volume":"27","author":"A Lau","year":"2024","unstructured":"Lau A, Prout T, Malabanan A, Szalat A, Krueger D, Tanner SB, et al. Reporting of full-length femur imaging to detect incomplete atypical femur fractures: 2023 official positions of the international society for clinical densitometry. J Clin Densitom. 2024;27:101439.","journal-title":"J Clin Densitom"},{"key":"1205_CR66","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jocd.2019.07.003","volume":"22","author":"AM Cheung","year":"2019","unstructured":"Cheung AM, McKenna MJ, van de Laarschot DM, Zillikens MC, Peck V, Srighanthan J, et al. Detection of atypical femur fractures. J Clin Densitom. 2019;22:506\u201316.","journal-title":"J Clin Densitom"},{"key":"1205_CR67","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jocd.2013.08.018","volume":"16","author":"S Petak","year":"2013","unstructured":"Petak S, Barbu CG, Yu EW, Fielding R, Mulligan K, Sabowitz B, et al. The official positions of the international society for clinical densitometry: body composition analysis reporting. J Clin Densitom. 2013;16:508\u201319.","journal-title":"J Clin Densitom"},{"key":"1205_CR68","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4103\/2230-8210.109659","volume":"17","author":"MK Garg","year":"2013","unstructured":"Garg MK, Kharb S. Dual energy X-ray absorptiometry: pitfalls in measurement and interpretation of bone mineral density. Indian J Endocrinol Metab. 2013;17:203\u201310.","journal-title":"Indian J Endocrinol Metab"},{"key":"1205_CR69","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s001980170049","volume":"12","author":"FP Girardi","year":"2001","unstructured":"Girardi FP, Parvataneni HK, Sandhu HS, Cammisa FP Jr., Grewal H, Schneider R, Lane JM. Correlation between vertebral body rotation and two-dimensional vertebral bone density measurement. Osteoporos Int. 2001;12:738\u201340.","journal-title":"Osteoporos Int"},{"key":"1205_CR70","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF01623225","volume":"4","author":"PJ Ryan","year":"1994","unstructured":"Ryan PJ, Blake GM, Herd R, Parker J, Fogelman I. Distribution of bone mineral density in the lumbar spine in health and osteoporosis. Osteoporos Int. 1994;4:67\u201371.","journal-title":"Osteoporos Int"},{"key":"1205_CR71","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jocd.2007.11.004","volume":"11","author":"SL Morgan","year":"2008","unstructured":"Morgan SL, Lopez-Ben R, Nunnally N, Burroughs L, Fineberg N, Tubbs RS, et al. The effect of common artifacts lateral to the spine on bone mineral density in the lumbar spine. J Clin Densitom. 2008;11:243\u20139.","journal-title":"J Clin Densitom"},{"key":"1205_CR72","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jocd.2005.12.002","volume":"9","author":"DL Kendler","year":"2006","unstructured":"Kendler DL, Kiebzak GM, Ambrose CG, Dinu C, Robertson S, Schmeer P, et al. Effect of calcium tablets on interpretation of lumbar spine DXA scans. J Clin Densitom. 2006;9:97\u2013104.","journal-title":"J Clin Densitom"},{"key":"1205_CR73","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2967\/jnmt.122.264885","volume":"51","author":"KP Banks","year":"2023","unstructured":"Banks KP, Farrell MB, Gunther RS, McWhorter NE, Byerly DW, Peacock JG. Improving DXA quality by avoiding common technical and diagnostic pitfalls: part 1. J Nucl Med Technol. 2023;51:167\u201375.","journal-title":"J Nucl Med Technol"},{"key":"1205_CR74","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.acra.2020.07.028","volume":"28","author":"D Albano","year":"2021","unstructured":"Albano D, Agnollitto PM, Petrini M, Biacca A, Ulivieri FM, Sconfienza LM, Messina C: Operator-Related Errors and Pitfalls in Dual Energy X-Ray Absorptiometry: How to Recognize and Avoid Them. Acad Radiol 2021, 28:1272-1286.","journal-title":"Acad Radiol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-025-01205-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-025-01205-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-025-01205-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:03:39Z","timestamp":1770750219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-025-01205-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1205"],"URL":"https:\/\/doi.org\/10.1007\/s11926-025-01205-9","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human and Animal Rights and Informed Consent: This article does not contain studies performed with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"38"}}